Fig. 1From: Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIPMedian pain scores following injection of 200 pmol VIP and 200 pmol PACAP38. Median pain score did not exceed 0 on any placebo day. Area under VAS-time curve was larger following VIP (P = 0.01) and PACAP38 (P = 0.004) compared to placeboBack to article page